Harbin, China

Zishi Wang

This inventor holds 1 USPTO granted patent. Top assignee: Heilongjiang University. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zishi Wang. Retrieved from https://idiyas.com/inventor/zishi-wang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zishi Wang: Innovator in Drug Property Prediction

Introduction

Zishi Wang is a notable inventor based in Harbin, China. He has made significant contributions to the field of drug property prediction through his innovative use of proteins. His work is particularly relevant in the development of pesticides, human drugs, and veterinary drugs.

Latest Patents

Zishi Wang holds a patent titled "Use of protein in predicting drug properties." This patent outlines a method that involves preparing a phosphate buffer solution, dissolving a protein solution, and mixing it with the drug to be tested. The process allows for the prediction of drug properties using various spectroscopic techniques, including fluorescence spectrum and UV-Vis absorption spectrum. He has 1 patent to his name.

Career Highlights

Zishi Wang is affiliated with Heilongjiang University, where he continues to advance research in the application of proteins in drug development. His academic background and research focus have positioned him as a key figure in this innovative field.

Collaborations

Zishi Wang has collaborated with notable colleagues, including Hongliang Xu and Qin Zhou. Their combined expertise enhances the research efforts in drug property prediction.

Conclusion

Zishi Wang's contributions to the field of drug property prediction through his innovative use of proteins demonstrate the potential for advancements in pharmaceuticals. His work continues to influence the development of effective drugs and treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…